Laurion Capital Management LP Pliant Therapeutics, Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.58 - $15.61 $10.3 Million - $15.2 Million	-975,824 Reduced 28.08%	2,498,920 $26.9 Million
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $1.54 Million - $2.13 Million	-108,823 Reduced 3.04%	3,474,744 $51.8 Million
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $5.46 Million - $8.14 Million	424,997 Added 13.46%	3,583,567 $64.9 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $57.2 Million - $96.5 Million	3,158,570 New	3,158,570 $57.2 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $1.93 Million - $4.12 Million	470,601 New	470,601 $3.77 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.